Follow us on:

Linkedin Facebook

Halma plc 19.6% Potential Decrease Indicated by Morgan Stanley

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Halma plc using EPIC/TICKER code (LON:HLMA) had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘EQUAL WEIGHT’ this morning by analysts at Morgan Stanley. Halma plc are listed in the Industrials sector within UK Main Market. Morgan Stanley have set a target price of 1680 GBX on its stock. This is indicating the analyst believes there is a potential downside of -19.6% from the opening price of 2089 GBX. Over the last 30 and 90 trading days the company share price has increased 186 points and increased 94.5 points respectively. The 1 year high for the share price is 2151 GBX while the 52 week low is 1275 GBX.

Halma plc has a 50 day moving average of 1,959.07 GBX and a 200 Day Moving Average share price is recorded at 1,903.99. There are currently 379,645,332 shares in issue with the average daily volume traded being 1,095,609. Market capitalisation for LON:HLMA is £7,911,808,052 GBP.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

    Latest Company News

    Broker Ratings

    Halma plc -11.6% potential downside indicated by Deutsche

    Halma plc

    Halma Plc achieves record profit for the 21st consecutive year

    Halma plc (LON:HLMA) has released its full year results for the year ending 31 March 2024. Explore the financial details and dividend information here.
    Broker Ratings

    Halma plc 16.4% potential upside indicated by Barclays

    Halma plc

    Halma Plc releases trading update showing strong growth and substantial strategic investments

    Halma plc (LON: HLMA) releases its trading update for the financial year, showing strong growth and strategic investments. Full year results expected on 13 June 2024.
    Halma plc

    Halma appoints Giles Kerr as an independent non-executive Director

    Halma plc has appointed Giles Kerr as an independent non-executive Director, bringing valuable insights from his extensive experience in life sciences and technology sectors. Roy Twite will step down as a Director on 7 June 2024.
    Broker Ratings

    Halma plc 16.8% potential upside indicated by Barclays

      Latest interviews

      View all interviews 

      Company Presentations

      View all Company Presentations

      Brokers Talk

      View all Broker Talk

      FTSE 100 News

      Search

      Search

      Green News

      View all Sustainable sectors, Plcs and news  

      Q&A's

      View all Question and Answers

      Funds

      View all Funds, Market Insights and news

      UK Broker Ratings

      Hardman & Co

      Don't Miss Our News Alerts

      Subscribe Free

      Find us on:

      Linkedin Facebook

      Useful links

      Disclaimer

      You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website.

      © 2024 – DirectorsTalk Interviews. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.